Robert Malone Steps Down From Vaccine Panel After Judge Blocks Work
WASHINGTON — Robert Malone, a physician and biochemist who served as an outspoken member of the Centers for Disease Control and Prevention’s (CDC) vaccine advisory committee, is stepping down following a federal judge’s ruling that effectively halted the panel’s recent work. The departure of Dr. Malone, an ideological ally of Health and Human Services Secretary Robert F. Kennedy Jr., marks another chapter in the ongoing reshaping of U.S. Vaccine policy under the current administration.
The decision follows a court order last week that blocked changes to the childhood vaccine schedule proposed by the Advisory Committee on Immunization Practices (ACIP). Judge Brian E. Murphy not only halted the proposed changes but too questioned the panel’s overall validity, effectively preventing it from taking further action. STAT News reported that the judge also restored the original vaccine schedule.
A Panel in Transition
Dr. Malone’s appointment to ACIP last year was part of a broader overhaul initiated by Secretary Kennedy, who expressed concerns that the previous panel was unduly influenced by pharmaceutical interests. This led to the appointment of several new members, including Dr. Malone, who had previously questioned the severity of the COVID-19 pandemic and promoted claims about the disease that were later debunked by organizations like FactCheck.org. The New York Times noted that Dr. Malone was appointed after a “purge” of previous advisors.
The ACIP panel’s recent actions, including a vote to delay the hepatitis B birth dose for infants, have been central to the Trump administration’s efforts to reshape vaccine policies. However, the administration’s move to unilaterally reduce the number of recommended pediatric vaccines earlier this year was not a decision made by ACIP. The current legal challenge and Dr. Malone’s subsequent departure highlight the complexities and tensions surrounding these policy shifts.
Conflicting Accounts and a Departure Driven by “Drama”
The circumstances surrounding Dr. Malone’s departure were marked by public disagreement. He initially posted on social media that ACIP had been disbanded, a statement he later clarified as a miscommunication. He also voiced strong criticism of Judge Murphy, calling for his impeachment on his X account.
The final catalyst for Dr. Malone’s resignation appears to have been a disagreement with Department of Health and Human Services (HHS) spokesperson Andrew Nixon regarding whether the court ruling would be appealed. According to Roll Call, Dr. Malone stated in a text message, “After Andrew trashing me with the press, I am done with the CDC and ACIP. That was the last straw.” He added, “Suffice to say I do not like drama, and have better things to do.” HHS has yet to announce a decision on whether to appeal the judge’s ruling.
What the Court Ruling Means for Vaccine Schedules
The federal judge’s decision effectively reinstates the previously recommended childhood vaccine schedule. This schedule, developed by the CDC and ACIP, outlines the recommended timing and types of vaccines for children from birth through adolescence. The changes proposed by the panel, and now blocked by the court, had sparked concern among medical professionals and public health advocates who argued they could potentially lower vaccination rates and increase the risk of preventable diseases.
The ruling underscores the importance of rigorous scientific review and evidence-based decision-making in vaccine policy. The judge’s concerns centered on the process followed by the ACIP panel, suggesting that it had not adequately considered all relevant data and perspectives. This highlights the need for transparency and inclusivity in the development of public health recommendations.
The Role of ACIP and Future Guidance
The Advisory Committee on Immunization Practices plays a crucial role in advising the CDC on vaccine-related matters. The committee is composed of medical and public health experts who review scientific data and make recommendations on vaccine use. These recommendations are then used to develop the CDC’s official immunization schedules and guidelines.
With the current panel effectively sidelined, the future of ACIP remains uncertain. The HHS has not yet indicated whether it plans to reform the panel or seek a new legal path forward. Any changes to the vaccine schedule will likely require a thorough review process, including public input and consideration of the latest scientific evidence. The American Academy of Pediatrics (AAP) filed the lawsuit that led to the judge’s ruling, and their position will likely be influential in shaping future discussions.
What Comes Next: A Period of Review and Potential Reconstitution
The immediate next steps involve the HHS determining whether to appeal Judge Murphy’s decision. If the ruling stands, the department will need to address the future of ACIP. This could involve reconstituting the panel with new members, revising the committee’s procedures, or seeking alternative mechanisms for developing vaccine recommendations. Public health officials will also be closely monitoring vaccination rates to assess the impact of the recent policy changes and legal challenges. Ongoing surveillance of vaccine-preventable diseases will be critical to inform future guidance and ensure the continued protection of public health.